{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-002575","form_type":"8-K","ticker":"SIGY","cik":"0001642159","company_name":"Sigyn Therapeutics, Inc.","filed_at":"2025-01-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.280545+00:00","generated_at":"2026-05-28T00:05:19.613161+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Sigyn Therapeutics appoints Michael Ryan to board effective Jan 11, 2025","bullets":["Michael Ryan appointed to board; will serve until next stockholder meeting or successor elected.","Ryan is a founder director of Irrus Investments, largest angel syndicate in Ireland, with €40M+ invested in 35 life science and tech firms.","Compensation: $30,000 annual cash retainer plus $50,000 in restricted stock units or options, vesting quarterly over one year.","Previously CEO of Sedana Medical (Nasdaq First North) and Artema Medical (acquired by Datascope)."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-002575","json":"https://secwatch.observer/filing/0001493152-25-002575.json","markdown":"https://secwatch.observer/filing/0001493152-25-002575.md","text":"https://secwatch.observer/filing/0001493152-25-002575.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1642159/000149315225002575/0001493152-25-002575-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1642159/000149315225002575/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T00:05:19.613161+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"11895cb13f","claim":"Michael Ryan was appointed as Director at Sigyn Therapeutics, Inc..","evidence_excerpt":"On January 11, 2025, our Board of Directors appointed Michael Ryan to our Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1642159/000149315225002575/0001493152-25-002575-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}